Literature DB >> 27957067

Effect Of Catheter Ablation On Quality Of Life In Atrial Fibrillation.

Jorge Gonzalez1, Laurent Macle1, Marc W Deyell2, Matthew T Bennett2, Marc Dubuc1, Katia Dyrda1, Peter G Guerra1, Paul Khairy1, Blandine Mondesert1, Léna Rivard1, Denis Roy1, Mario Talajic1, Bernard Thibault1, Jason G Andrade3.   

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia seen in clinical practice, affecting approximately 1% of the overall population. While rarely life-threatening, AF is almost universally associated with increased morbidity and mortality, predominantly through an increased risk of thromboembolic events, left ventricular dysfunction, as well as significant impairments in functional capacity and health-related quality of life (HRQOL).[1-8] Improvement in HRQOL, with a secondary reduction of disability and health-care resource utilization, is one of the major therapeutic goals in the management of AF.

Entities:  

Keywords:  Ablation/ICD/Surgery; Arrhythmias; Clinical Electrophysiology; Drugs; Electrophysiology

Year:  2014        PMID： 27957067      PMCID： PMC5135244          DOI： 10.4022/jafib.1063

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


  65 in total

1.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation.

Authors:  Hakan Oral; Carlo Pappone; Aman Chugh; Eric Good; Frank Bogun; Frank Pelosi; Eric R Bates; Michael H Lehmann; Gabriele Vicedomini; Giuseppe Augello; Eustachio Agricola; Simone Sala; Vincenzo Santinelli; Fred Morady
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

2.  Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias.

Authors:  A G Manolis; A G Katsivas; E E Lazaris; C V Vassilopoulos; N E Louvros
Journal:  J Interv Card Electrophysiol       Date:  1998-03       Impact factor: 1.900

3.  Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function.

Authors:  Claudio Tondo; Massimo Mantica; Giovanni Russo; Andrea Avella; Lucia De Luca; Augusto Pappalardo; Rafael Lopes Fagundes; Edo Picchio; Francesco Laurenzi; Vito Piazza; Irma Bisceglia
Journal:  Pacing Clin Electrophysiol       Date:  2006-09       Impact factor: 1.976

4.  Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers.

Authors:  E P Gerstenfeld; P Guerra; P B Sparks; K Hattori; M D Lesh
Journal:  J Cardiovasc Electrophysiol       Date:  2001-08

5.  Amiodarone versus sotalol for atrial fibrillation.

Authors:  Bramah N Singh; Steven N Singh; Domenic J Reda; X Charlene Tang; Becky Lopez; Crystal L Harris; Ross D Fletcher; Satish C Sharma; J Edwin Atwood; Alan K Jacobson; H Daniel Lewis; Dennis W Raisch; Michael D Ezekowitz
Journal:  N Engl J Med       Date:  2005-05-05       Impact factor: 91.245

Review 6.  Quality of life in patients with atrial fibrillation: a systematic review.

Authors:  Graham Thrall; Deirdre Lane; Douglas Carroll; Gregory Y H Lip
Journal:  Am J Med       Date:  2006-05       Impact factor: 4.965

7.  Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.

Authors:  Carlo Pappone; Salvatore Rosanio; Giuseppe Augello; Giuseppe Gallus; Gabriele Vicedomini; Patrizio Mazzone; Simone Gulletta; Filippo Gugliotta; Alessia Pappone; Vincenzo Santinelli; Valter Tortoriello; Simone Sala; Alberto Zangrillo; Giuseppe Crescenzi; Stefano Benussi; Ottavio Alfieri
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

8.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.

Authors:  Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

9.  Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life.

Authors:  Jacob Pontoppidan; Jens Cosedis Nielsen; Steen Hvitfeldt Poulsen; Peter Steen Hansen
Journal:  Pacing Clin Electrophysiol       Date:  2009-06       Impact factor: 1.976

10.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

Authors:  David J Wilber; Carlo Pappone; Petr Neuzil; Angelo De Paola; Frank Marchlinski; Andrea Natale; Laurent Macle; Emile G Daoud; Hugh Calkins; Burr Hall; Vivek Reddy; Giuseppe Augello; Matthew R Reynolds; Chandan Vinekar; Christine Y Liu; Scott M Berry; Donald A Berry
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272
View more
  1 in total

1.  Predictors of improvement in arrhythmia-specific symptoms and health-related quality of life after catheter ablation of atrial fibrillation.

Authors:  Neshro Barmano; Emmanouil Charitakis; Jan-Erik Karlsson; Fredrik H Nystrom; Håkan Walfridsson; Ulla Walfridsson
Journal:  Clin Cardiol       Date:  2018-12-21       Impact factor: 2.882
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.